Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs

Abstract Background With the improvement of treatment and prognosis for patients with late malignant diseases, certain malignancies with distant metastasis (M1 category) have been further classified into M1a (single metastatic site) and M1b (multiple metastatic sites) category in the staging system....

Full description

Bibliographic Details
Main Authors: Fang Feng, Wei Cai, Gaoming Wang, Weigang Chen, Haochang Yang, Mingyu Sun, Li Zhou
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Gastroenterology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12876-020-01431-8
_version_ 1828854452247855104
author Fang Feng
Wei Cai
Gaoming Wang
Weigang Chen
Haochang Yang
Mingyu Sun
Li Zhou
author_facet Fang Feng
Wei Cai
Gaoming Wang
Weigang Chen
Haochang Yang
Mingyu Sun
Li Zhou
author_sort Fang Feng
collection DOAJ
description Abstract Background With the improvement of treatment and prognosis for patients with late malignant diseases, certain malignancies with distant metastasis (M1 category) have been further classified into M1a (single metastatic site) and M1b (multiple metastatic sites) category in the staging system. We aimed to assess the feasibility of sub-classifying metastatic pancreatic adenocarcinoma (mPA) into M1a and M1b category depending on the number of metastatic organs. Methods Patient records were collected from the Surveillance, Epidemiology, and End Results (SEER) database (2010–2015). Univariable and multivariable analyses were performed using the Cox regression model. Then survival analysis was determined using the Kaplan–Meier method. Results A total of 11,885 patients were included in this analysis, including 9425 patients with single metastasis and 2460 patients with multiple metastases. Multivariable analysis showed that gender, age, marital status, grade, surgery, chemotherapy, and radiotherapy were independent prognostic factors for patients with single metastasis; gender, age, marital status, grade, chemotherapy and radiotherapy were independent prognostic factors for patients with multiple metastases. Notably, surgery was an independent prognostic factor for patients with single metastasis (P < 0.001) but not for patients with multiple metastases (P = 0.134). Kaplan–Meier analysis showed that patients with single metastasis (M1a) had better survival outcomes than patients with multiple metastases (M1b) (P < 0.001). Conclusions PA patients with M1 diseases could be divided into M1a (single metastasis) category and M1b (multiple metastases) category by the number of metastatic organs. The subclassification would facilitate individualized treatment for late PA patients. Surgery was associated with lower mortality in M1a patients but not significantly in M1b patients.
first_indexed 2024-12-13T00:34:24Z
format Article
id doaj.art-4c185f7a81de4cd9abf515242fba504a
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-13T00:34:24Z
publishDate 2020-08-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-4c185f7a81de4cd9abf515242fba504a2022-12-22T00:05:15ZengBMCBMC Gastroenterology1471-230X2020-08-012011810.1186/s12876-020-01431-8Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organsFang Feng0Wei Cai1Gaoming Wang2Weigang Chen3Haochang Yang4Mingyu Sun5Li Zhou6Department of Oncology, Suzhou Ninth People’s HospitalDepartment of Thoracic Surgery, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast UniversityDepartment of Thoracic Surgery, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast UniversityDepartment of Thoracic Surgery, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast UniversityCollege of Clinical Medicine, Binzhou Medical UniversityDepartment of Breast Surgery, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast UniversityDepartment of Oncology, Suzhou Ninth People’s HospitalAbstract Background With the improvement of treatment and prognosis for patients with late malignant diseases, certain malignancies with distant metastasis (M1 category) have been further classified into M1a (single metastatic site) and M1b (multiple metastatic sites) category in the staging system. We aimed to assess the feasibility of sub-classifying metastatic pancreatic adenocarcinoma (mPA) into M1a and M1b category depending on the number of metastatic organs. Methods Patient records were collected from the Surveillance, Epidemiology, and End Results (SEER) database (2010–2015). Univariable and multivariable analyses were performed using the Cox regression model. Then survival analysis was determined using the Kaplan–Meier method. Results A total of 11,885 patients were included in this analysis, including 9425 patients with single metastasis and 2460 patients with multiple metastases. Multivariable analysis showed that gender, age, marital status, grade, surgery, chemotherapy, and radiotherapy were independent prognostic factors for patients with single metastasis; gender, age, marital status, grade, chemotherapy and radiotherapy were independent prognostic factors for patients with multiple metastases. Notably, surgery was an independent prognostic factor for patients with single metastasis (P < 0.001) but not for patients with multiple metastases (P = 0.134). Kaplan–Meier analysis showed that patients with single metastasis (M1a) had better survival outcomes than patients with multiple metastases (M1b) (P < 0.001). Conclusions PA patients with M1 diseases could be divided into M1a (single metastasis) category and M1b (multiple metastases) category by the number of metastatic organs. The subclassification would facilitate individualized treatment for late PA patients. Surgery was associated with lower mortality in M1a patients but not significantly in M1b patients.http://link.springer.com/article/10.1186/s12876-020-01431-8Metastatic pancreatic adenocarcinomaSEEROverall survivalAJCC
spellingShingle Fang Feng
Wei Cai
Gaoming Wang
Weigang Chen
Haochang Yang
Mingyu Sun
Li Zhou
Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
BMC Gastroenterology
Metastatic pancreatic adenocarcinoma
SEER
Overall survival
AJCC
title Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
title_full Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
title_fullStr Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
title_full_unstemmed Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
title_short Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
title_sort metastatic pancreatic adenocarcinomas could be classified into m1a and m1b category by the number of metastatic organs
topic Metastatic pancreatic adenocarcinoma
SEER
Overall survival
AJCC
url http://link.springer.com/article/10.1186/s12876-020-01431-8
work_keys_str_mv AT fangfeng metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT weicai metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT gaomingwang metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT weigangchen metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT haochangyang metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT mingyusun metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans
AT lizhou metastaticpancreaticadenocarcinomascouldbeclassifiedintom1aandm1bcategorybythenumberofmetastaticorgans